Sartorius Aktiengesellschaft Non-GAAP EPS of €2.49, revenue of €1.81B
Seeking Alpha ·
Sartorius Aktiengesellschaft press release ( SARTF ): 1H Non-GAAP EPS of €2.49. In the first half of 2026, underlying EBITDA increased by 3.9% to €547.8 million. Management continues to expect sales revenue growth in constant currencies
AI 시장 분석
According to the first-half financial results released by Sartorius Aktiengesellschaft, Non-GAAP EPS was 2.49 euros and revenue reached 1.81 billion euros. H1 underlying EBITDA increased by 3.9% year-over-year to 547.8 million euros, demonstrating stable growth. Management's forecast of continuous revenue growth on a constant currency basis is restoring market confidence. Investors should closely monitor the recovery pace of bioprocess equipment demand and profit margin improvement trends.
상승 영향
- Biotechnology — Underlying EBITDA increased by 3.9% to 547.8 million euros, proving the recovery in demand for bioprocess equipment and pharmaceutical infrastructure.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 42% · Bearish (Short) 58%
436 participants
Related News
- House narrowly passes $1.15 trillion defense bill as Senate hurdles remain
- Nexstar slips as state AGs accuse the company of violating the Tegna integration order
- Sequoia Fund exits AMTM, LBRDK, and CACC
- Palisade Bio jumps following Oppenheimer outperform initiation
- Valley National outlines efficiency ratio at 50% or lower by exit 2026 while maintaining 2026 outlook
- Gentherm soars after Q2 beat and raised outlook
